Indications for Orphenadrine Citrate Extended-Release:
Painful musculoskeletal conditions.
100mg twice daily (AM and PM).
Orphenadrine Citrate Extended-Release Contraindications:
Glaucoma. Achalasia. GU or GI obstruction. Myasthenia gravis.
Orphenadrine Citrate Extended-Release Warnings/Precautions:
Coronary disease, insufficiency, or arrhythmias. Asthma (inj). Monitor blood, urine, and liver in long-term use. Pregnancy (Cat.C). Nursing mothers.
Orphenadrine Citrate Extended-Release Classification:
Orphenadrine Citrate Extended-Release Interactions:
Potentiates anticholinergics, alcohol, other CNS depressants, MAOIs, antidepressants. Tremors, mental confusion with propoxyphene. Antagonizes steroids, barbiturates, phenylbutazone.
Tachycardia, transient dizziness or syncope, other anticholinergic effects (eg, weakness, increased intraocular pressure, urinary retention, blurred vision, dry mouth), GI upset.
Formerly known under the brand name Norflex.